Application of cx4945 as a medicine for reversing cisplatin-resistant radiation tolerance in gastric cancer
A technology of CX4945 and radiation tolerance, which is applied in the direction of drug combination, pharmaceutical formula, antineoplastic drugs, etc., to reduce the effect of radiotherapy response, improve curative effect, and reduce the killing dose of radiotherapy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0038] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments, which are explanations rather than limitations of the present invention.
[0039] The CX4945 used in the following examples was purchased from Selleck, and the radiotherapy equipment was a Varian 2300 linear accelerator.
[0040] The following examples further illustrate the present invention through cell biology and molecular biology experiments of CX4945 on the reversal of radiation tolerance of gastric cancer drug-resistant cells, but it does not mean that the present invention is limited to this example
[0041] CX4945 is made into various dosage forms by adding pharmaceutically acceptable excipients according to conventional methods, such as liquid injections of various specifications, powder injections, emulsions for injections, tablets, pills, capsules, ointments, creams, patches, wipes, etc. Elixir, powder, spray, implant, drop,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com